Charles A Rowland Jr Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Charles A Rowland Jr.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Charles A Rowland Jr. Charles A Rowland Jr is EVP, CFO & Treasurer in ENDO HEALTH SOLUTIONS INC. ($ENDP) and Director in Vitae Pharmaceuticals, Inc ($VTAE) and Director in BIND Therapeutics, Inc ($BIND) and Director in Blueprint Medicines Corp ($BPMC) and Director in Viking Therapeutics, Inc. ($VKTX) and Director in Nabriva Therapeutics plc ($NBRV) and Director in Nabriva Therapeutics Plc ($NBRV) and in Generation Bio Co. ($GBIO) and Director in Generation Bio Co. ($GBIO) and Director in Orchard Therapeutics plc ($ORTX).
Latest Insider Trading Transactions of Charles A Rowland Jr
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BPMC, BIND, ENDP, GBIO, NBRV, NBRV, ORTX, VKTX, VTAE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13 2021 | GBIO | Generation Bio Co. | Rowland Charles A Jr | Buy | P | 24.50 | 20,408 | 499,996 | 101,035 | 80.6 K to 101 K (+25.31 %) | |
| Jan 06 2021 | VKTX | Viking Therapeutic ... | Rowland Charles A Jr | Director | Option Exercise | A | 5.80 | 22,000 | 127,600 | 22,000 | |
| Dec 18 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 19.53 | 10,909 | 213,053 | 0 | |
| Dec 18 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 117.82 | 10,909 | 1,285,298 | 3,562 | 14.5 K to 3.6 K (-75.39 %) |
| Dec 18 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 19.53 | 10,909 | 213,053 | 14,471 | 3.6 K to 14.5 K (+306.26 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 9.46 | 5,522 | 52,238 | 0 | |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 9.46 | 4,478 | 42,362 | 5,522 | |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 95.97 | 694 | 66,603 | 3,562 | 4.3 K to 3.6 K (-16.31 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 99.10 | 4,728 | 468,545 | 4,256 | 9 K to 4.3 K (-52.63 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 100.48 | 100 | 10,048 | 8,984 | 9.1 K to 9 K (-1.10 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 9.46 | 5,522 | 52,238 | 9,084 | 3.6 K to 9.1 K (+155.03 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 99.11 | 4,478 | 443,815 | 3,562 | 8 K to 3.6 K (-55.70 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 9.46 | 4,478 | 42,362 | 8,040 | 3.6 K to 8 K (+125.72 %) |
| Jul 31 2020 | NBRV | Nabriva Therapeuti ... | Rowland Charles A Jr | Director | Option Exercise | A | 0.79 | 35,000 | 27,650 | 35,000 | |
| Jul 31 2020 | NBRV | Nabriva Therapeuti ... | Rowland Charles A Jr | Director | Grant | A | 0.00 | 17,500 | 0 | 70,500 | 53 K to 70.5 K (+33.02 %) |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 76.24 | 4,500 | 343,080 | 4,500 | |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Grant | A | 0.00 | 2,250 | 0 | 3,562 | 1.3 K to 3.6 K (+171.49 %) |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 0.00 | 1,312 | 0 | 0 | |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 0.00 | 1,312 | 0 | 1,312 | 0 to 1.3 K |
| Jun 19 2020 | ORTX | Orchard Therapeuti ... | Rowland Charles A Jr | Director | Option Exercise | A | 7.81 | 35,000 | 273,350 | 35,000 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Option Exercise | C | 0.00 | 89,423 | 0 | 0 | |
| Jun 18 2020 | GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Buy | P | 19.00 | 30,000 | 570,000 | 80,627 | 50.6 K to 80.6 K (+59.26 %) |
| Jun 18 2020 | GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Buy | C | 0.00 | 50,627 | 0 | 50,627 | 0 to 50.6 K |
| Jun 15 2020 | GBIO | Generation Bio Co. | Rowland Charles A Jr | Director | Option Exercise | A | 19.00 | 52,000 | 988,000 | 52,000 | |
| Jan 03 2020 | VKTX | Viking Therapeutic ... | Rowland Charles A Jr | Director | Option Exercise | A | 7.95 | 22,000 | 174,900 | 22,000 | |
| Aug 01 2019 | NBRV | Nabriva Therapeuti ... | Rowland Charles A Jr | Director | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
| Jun 24 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 9.46 | 11,818 | 111,798 | 10,000 | |
| Jun 24 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 94.83 | 9,271 | 879,169 | 0 | 9.3 K to 0 (-100.00 %) |
| Jun 24 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 96.08 | 1,600 | 153,728 | 9,271 | 10.9 K to 9.3 K (-14.72 %) |
| Jun 24 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 96.69 | 947 | 91,565 | 10,871 | 11.8 K to 10.9 K (-8.01 %) |
| Jun 24 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 9.46 | 11,818 | 111,798 | 11,818 | 0 to 11.8 K |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 0.00 | 1,312 | 0 | 1,312 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 96.77 | 4,875 | 471,754 | 4,875 | |
| Jan 03 2019 | VKTX | Viking Therapeutic ... | Rowland Charles A Jr | Director | Option Exercise | A | 8.32 | 22,000 | 183,040 | 22,000 | |
| Dec 27 2018 | NBRV | Nabriva Therapeuti ... | Rowland Charles A Jr | Director | Buy | P | 1.31 | 53,000 | 69,430 | 53,000 | 0 to 53 K |
| Aug 02 2018 | NBRV | Nabriva Therapeuti ... | Rowland Charles A Jr | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Jun 25 2018 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 69.79 | 7,500 | 523,425 | 51,136 | |
| May 31 2018 | VKTX | Viking Therapeutic ... | Rowland Charles A Jr | Director | Buy | P | 5.16 | 30,000 | 154,800 | 30,000 | 0 to 30 K |
| May 04 2018 | NBRV | Nabriva Therapeuti ... | Rowland Charles A Jr | Director | Option Exercise | A | 0.00 | 29,000 | 0 | 29,000 | |
| Sep 19 2017 | NBRV | Nabriva Therapeuti ... | Rowland Charles A Jr | Director | Option Exercise | A | 0.00 | 10,100 | 0 | 10,100 | |
| Jul 05 2017 | VKTX | Viking Therapeutic ... | Rowland Charles A Jr | Director | Option Exercise | A | 1.08 | 40,000 | 43,200 | 40,000 | |
| Jun 27 2017 | NBRV | Nabriva Therapeuti ... | Rowland Charles A Jr | Director | Option Exercise | J | 0.00 | 10,100 | 0 | 10,100 | |
| Jun 27 2017 | NBRV | Nabriva Therapeuti ... | Rowland Charles A Jr | Director | Option Exercise | J | 0.00 | 16,000 | 0 | 16,000 | |
| Jun 23 2017 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 43,636 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Rowland Charles A Jr | Director | Option Exercise | D | 9.62 | 10,000 | 96,200 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Rowland Charles A Jr | Director | Option Exercise | D | 12.43 | 10,000 | 124,300 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Rowland Charles A Jr | Director | Option Exercise | D | 8.00 | 17,000 | 136,000 | 0 | |
| Aug 30 2016 | BIND | DNIB UNWIND, INC. | Rowland Charles A Jr | Director | Option Exercise | M | 0.44 | 15,000 | 6,600 | 0 | |
| Aug 30 2016 | BIND | DNIB UNWIND, INC. | Rowland Charles A Jr | Director | Buy | M | 0.44 | 15,000 | 6,600 | 15,000 | 0 to 15 K |
| Jun 27 2016 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 19.53 | 10,909 | 213,053 | 32,727 | |
| Jun 22 2016 | BIND | BIND Therapeutics, ... | Rowland Charles A Jr | Director | Option Exercise | A | 0.44 | 15,000 | 6,600 | 15,000 | |
| May 27 2016 | VTAE | Vitae Pharmaceutic ... | Rowland Charles A Jr | Director | Option Exercise | A | 9.62 | 10,000 | 96,200 | 10,000 | |
| Jun 10 2015 | BIND | BIND Therapeutics, ... | Rowland Charles A Jr | Director | Option Exercise | A | 5.87 | 15,000 | 88,050 | 15,000 | |
| Jun 01 2015 | VTAE | Vitae Pharmaceutic ... | Rowland Charles A Jr | Director | Option Exercise | A | 12.43 | 10,000 | 124,300 | 10,000 | |
| Feb 25 2008 | ENDP | ENDO HEALTH SOLUTI ... | Rowland Charles A Jr | EVP, CFO & Treasure ... | Option Exercise | A | 25.19 | 48,866 | 1,230,935 | 48,866 | |
| Feb 25 2008 | ENDP | ENDO HEALTH SOLUTI ... | Rowland Charles A Jr | EVP, CFO & Treasure ... | Grant | A | 0.00 | 6,699 | 0 | 6,699 | 0 to 6.7 K |
| Jan 29 2008 | ENDP | ENDO HEALTH SOLUTI ... | Rowland Charles A Jr | EVP, CFO & Treasure ... | Option Exercise | A | 24.87 | 75,000 | 1,865,250 | 75,000 |
Page: 1